SCHEMBL21884033

SCHEMBL21884033

Cc1cccc(C2COC2)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
TRPA1 O75762 2/20 0.43
GABRA1 P14867 1/20 0.38
GABRB2 P47870 1/20 0.38
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
HTR2C P28335 7/20 0.37
MAP3K14 Q99558 1/20 0.36
MAPT P10636 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2C19 P33261 1/20 0.35
ATM Q13315 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2B P41595 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15517656 0.86 ALDH1A1 (0.42) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL930208 0.82 ALDH1A1 (0.54) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL17297901 0.79 HTR2C (0.53) ALDH1A1HTR2CHTR2AHTR2BTAAR1
SCHEMBL466853 0.78 ALDH1A1 (0.50) ALDH1A1TRPA1GABRA1GABRB2HPGD
SCHEMBL8954630 0.77 ALDH1A1 (0.48) ALDH1A1TRPA1GABRA1GABRB2HTR2C
SCHEMBL18512269 0.77 KDM1A (0.34) HTR2CHTR2AHTR2B
SCHEMBL673222 0.77 ALDH1A1 (0.48) ALDH1A1TRPA1GABRA1GABRB2HTR2C
SCHEMBL30218222 0.77 ALDH1A1 (0.48) ALDH1A1TRPA1GABRA1GABRB2HTR2C
SCHEMBL22096912 0.77 CA2 (0.53) ALDH1A1GABRA1GABRB2ATM
SCHEMBL19769063 0.77 GABRA1 (0.53) ALDH1A1GABRA1GABRB2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597377-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 ALDH1A1 4626/4885TRPA1 1736/4885GABRA1 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.